Breakthrough Study Reveals How IGF Signalling Builds Lymphatic Vessels in Zebrafish

A new study has uncovered how insulin-like growth factor (IGF) signalling shapes the development of lymphatic vessels in zebrafish. Researchers used the transparent larvae to observe vessel formation in real time, revealing key mechanisms behind this process. The findings could pave the way for future treatments targeting lymphatic disorders like lymphedema.

The team focused on IGF signalling, which controls the growth, movement, and specialisation of lymphatic endothelial cells. By tracking these cells in zebrafish larvae, they observed how IGF influences vessel branching and stability. Disrupting this signalling impaired the production of essential proteins and adhesion molecules, leading to abnormal vessel patterns.

RNA sequencing helped identify the specific genes activated by IGF, mapping out the pathways involved in lymphatic vessel formation. The study highlighted a delicate balance: too much or too little IGF signalling disrupted normal vessel development. While the results suggest therapeutic potential, no clinical trials targeting IGF for lymphedema have been launched in the past five years, according to global trial databases.

The transparency of zebrafish larvae allowed continuous monitoring of vessel dynamics, providing a clear view of how IGF signalling orchestrates lymphangiogenesis. These insights deepen the understanding of vertebrate lymphatic biology and offer a foundation for exploring new treatments.

The research demonstrates that precise IGF signalling is crucial for proper lymphatic vessel formation. By pinpointing the genes and pathways involved, scientists have opened potential avenues for repairing or regenerating damaged lymphatic systems. However, further studies will be needed before these findings can translate into clinical applications for conditions like lymphedema.